Systematic Review of SLC4A11, ZEB1, LOXHD1, and AGBL1 Variants in the Development of Fuchs' Endothelial Corneal Dystrophy

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2023 Jul 13

PMID 37441688

Authors

Tatiana Romanovna Tsedilina

Elena Sharova

Valeriia Iakovets

Liubov Olegovna Skorodumova

Affiliations

Soon will be listed here.

Abstract

Introduction: The pathogenic role of variants in TCF4 and COL8A2 in causing Fuchs' endothelial corneal dystrophy (FECD) is not controversial and has been confirmed by numerous studies. The causal role of other genes, SLC4A11, ZEB1, LOXHD1, and AGBL1, which have been reported to be associated with FECD, is more complicated and less obvious. We performed a systematic review of the variants in the above-mentioned genes in FECD cases, taking into account the currently available population frequency information, transcriptomic data, and the results of functional studies to assess their pathogenicity.

Methods: Search for articles published in 2005-2022 was performed manually between July 2022 and February 2023. We searched for original research articles in peer-reviewed journals, written in English. Variants in the genes of interest identified in patients with FECD were extracted for the analysis. We classified each presented variant by pathogenicity status according to the ACMG criteria implemented in the Varsome tool. Diagnosis, segregation data, presence of affected relatives, functional analysis results, and gene expression in the corneal endothelium were taken into account. Data on the expression of genes of interest in the corneal endothelium were extracted from articles in which transcriptome analysis was performed. The identification of at least one variant in a gene classified as pathogenic or significantly associated with FECD was required to confirm the causal role of the gene in FECD.

Results: The analysis included 34 articles with 102 unique ZEB1 variants, 20 articles with 64 SLC4A11 variants, six articles with 26 LOXHD1 variants, and five articles with four AGBL1 variants. Pathogenic status was confirmed for seven SLC4A11 variants found in FECD. No variants in ZEB1, LOXHD1, and AGBL1 genes were classified as pathogenic for FECD. According to the transcriptome data, AGBL1 and LOXHD1 were not expressed in the corneal endothelium. Functional evidence for the association of LOXHD1, and AGBL1 with FECD was conflicting.

Conclusion: Our analysis confirmed the causal role of SLC4A11 variants in the development of FECD. The causal role of ZEB1, LOXHD1, and AGBL1 variants in FECD has not been confirmed. Further evidence from familial cases and functional analysis is needed to confirm their causal roles in FECD.

Citing Articles

Expression and Impact of Fibronectin, Tenascin-C, Osteopontin, and Type XIV Collagen in Fuchs Endothelial Corneal Dystrophy.

Tchatchouang A, Brunette I, Rochette P, Proulx S Invest Ophthalmol Vis Sci. 2024; 65(4):38.

PMID: 38656280 PMC: 11044831. DOI: 10.1167/iovs.65.4.38.

References

Riazuddin S, Vasanth S, Katsanis N, Gottsch J . Mutations in AGBL1 cause dominant late-onset Fuchs corneal dystrophy and alter protein-protein interaction with TCF4. Am J Hum Genet. 2013; 93(4):758-64. PMC: 3791265. DOI: 10.1016/j.ajhg.2013.08.010. View

Soumittra N, Loganathan S, Madhavan D, Ramprasad V, Arokiasamy T, Sumathi S . Biosynthetic and functional defects in newly identified SLC4A11 mutants and absence of COL8A2 mutations in Fuchs endothelial corneal dystrophy. J Hum Genet. 2014; 59(8):444-53. DOI: 10.1038/jhg.2014.55. View

Rong Z, Hu J, Corey D, Mootha V . Quantitative Studies of Muscleblind Proteins and Their Interaction With TCF4 RNA Foci Support Involvement in the Mechanism of Fuchs' Dystrophy. Invest Ophthalmol Vis Sci. 2019; 60(12):3980-3991. PMC: 6779288. DOI: 10.1167/iovs.19-27641. View

Bakhtiari P, Frausto R, Roldan A, Wang C, Yu F, Aldave A . Exclusion of pathogenic promoter region variants and identification of novel nonsense mutations in the zinc finger E-box binding homeobox 1 gene in posterior polymorphous corneal dystrophy. Mol Vis. 2013; 19:575-80. PMC: 3611940. View

Chaudhry A, Chung B, Stavropoulos D, Araya M, Ali A, Heon E . Agenesis of the corpus callosum, developmental delay, autism spectrum disorder, facial dysmorphism, and posterior polymorphous corneal dystrophy associated with ZEB1 gene deletion. Am J Med Genet A. 2017; 173(9):2467-2471. DOI: 10.1002/ajmg.a.38321. View

Yellore V, Rayner S, Nguyen C, Gangalum R, Jing Z, Bhat S . Analysis of the role of ZEB1 in the pathogenesis of posterior polymorphous corneal dystrophy. Invest Ophthalmol Vis Sci. 2011; 53(1):273-8. PMC: 3292363. DOI: 10.1167/iovs.11-8038. View

Zhang J, Wu D, Li Y, Fan Y, Chen H, Hong J . Novel Mutations Associated With Various Types of Corneal Dystrophies in a Han Chinese Population. Front Genet. 2019; 10:881. PMC: 6726741. DOI: 10.3389/fgene.2019.00881. View

Liskova P, Evans C, Davidson A, Zaliova M, Dudakova L, Trkova M . Heterozygous deletions at the ZEB1 locus verify haploinsufficiency as the mechanism of disease for posterior polymorphous corneal dystrophy type 3. Eur J Hum Genet. 2015; 24(7):985-91. PMC: 5070886. DOI: 10.1038/ejhg.2015.232. View

Rao B, Tharigopala A, Rachapalli S, Rajagopal R, Soumittra N . Association of polymorphisms in the intron of gene to late-onset Fuchs endothelial corneal dystrophy: An Indian cohort study. Indian J Ophthalmol. 2017; 65(10):931-935. PMC: 5678327. DOI: 10.4103/ijo.IJO_191_17. View

10.

GOAR E . Dystrophy of the Corneal Endothelium (Cornea Guttata), with Report of a Histologic Examination. Trans Am Ophthalmol Soc. 1933; 31:48-59. PMC: 1315418. View

11.

Afshari N, Igo Jr R, Morris N, Stambolian D, Sharma S, Pulagam V . Genome-wide association study identifies three novel loci in Fuchs endothelial corneal dystrophy. Nat Commun. 2017; 8:14898. PMC: 5379100. DOI: 10.1038/ncomms14898. View

12.

Thaung C, Davidson A . Fuchs endothelial corneal dystrophy: current perspectives on diagnostic pathology and genetics-Bowman Club Lecture. BMJ Open Ophthalmol. 2022; 7(1). PMC: 9341215. DOI: 10.1136/bmjophth-2022-001103. View

13.

Krachmer J, Purcell Jr J, Young C, Bucher K . Corneal endothelial dystrophy. A study of 64 families. Arch Ophthalmol. 1978; 96(11):2036-9. DOI: 10.1001/archopht.1978.03910060424004. View

14.

Li D, Peng X, Sun H . Association of TCF4 polymorphisms and Fuchs' endothelial dystrophy: a meta-analysis. BMC Ophthalmol. 2015; 15:61. PMC: 4474332. DOI: 10.1186/s12886-015-0055-6. View

15.

Vilas G, Loganathan S, Quon A, Sundaresan P, Vithana E, Casey J . Oligomerization of SLC4A11 protein and the severity of FECD and CHED2 corneal dystrophies caused by SLC4A11 mutations. Hum Mutat. 2011; 33(2):419-28. DOI: 10.1002/humu.21655. View

16.

Liskova P, Prescott Q, Bhattacharya S, Tuft S . British family with early-onset Fuchs' endothelial corneal dystrophy associated with p.L450W mutation in the COL8A2 gene. Br J Ophthalmol. 2007; 91(12):1717-8. PMC: 2095500. DOI: 10.1136/bjo.2007.115154. View

17.

Sultana A, Garg P, Ramamurthy B, Vemuganti G, Kannabiran C . Mutational spectrum of the SLC4A11 gene in autosomal recessive congenital hereditary endothelial dystrophy. Mol Vis. 2007; 13:1327-32. View

18.

Grillet N, Schwander M, Hildebrand M, Sczaniecka A, Kolatkar A, Velasco J . Mutations in LOXHD1, an evolutionarily conserved stereociliary protein, disrupt hair cell function in mice and cause progressive hearing loss in humans. Am J Hum Genet. 2009; 85(3):328-37. PMC: 2771534. DOI: 10.1016/j.ajhg.2009.07.017. View

19.

Kuot A, Hewitt A, Griggs K, Klebe S, Mills R, Jhanji V . Association of TCF4 and CLU polymorphisms with Fuchs' endothelial dystrophy and implication of CLU and TGFBI proteins in the disease process. Eur J Hum Genet. 2012; 20(6):632-8. PMC: 3355250. DOI: 10.1038/ejhg.2011.248. View

20.

Souzeau E, Siggs O, Mullany S, Schmidt J, Hassall M, Dubowsky A . Diagnostic yield of candidate genes in an Australian corneal dystrophy cohort. Mol Genet Genomic Med. 2022; 10(10):e2023. PMC: 9544209. DOI: 10.1002/mgg3.2023. View